May 30, 2025 07:07 AM EDTUpdated 08:04 AM

Sanofi, Regeneron report underwhelming COPD data for IL-33 antibody, shares drop

Ayisha Sharma

News Reporter

Sanofi and Regeneron on Friday reported lackluster late-stage results for their drug candidate in a common lung condition, leaving the partners to patch together a …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Sanofi, Regeneron report underwhelming COPD data for IL-33 antibody, shares drop

Ayisha Sharma

News Reporter

Sign up to read this article for free.

FDA approves Moderna’s next-gen Covid vaccine, with limits on most healthy people

Summit’s disappointing survival readout raises stakes for full data

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Summit says bispecific misses overall survival in closely-watched lung cancer study

Gilead, Merck reveal 'practice-changing' data for Trodelvy-Keytruda combo in aggressive breast cancer

From weeks to days: how Aizon Intelligent Agents transform pharma validation

Sanofi, Re­gen­eron re­port un­der­whelm­ing COPD da­ta for IL-33 an­ti­body, shares drop

Ayisha Sharma

News Reporter

Sign up to read this article for free.

FDA ap­proves Mod­er­na’s next-gen Covid vac­cine, with lim­its on most healthy peo­ple

Sum­mit’s dis­ap­point­ing sur­vival read­out rais­es stakes for full da­ta

Up­dat­ed: Pa­tient dies in Rock­et gene ther­a­py tri­al, which is put on clin­i­cal hold by FDA

Sum­mit says bis­pe­cif­ic miss­es over­all sur­vival in close­ly-watched lung can­cer study

Gilead, Mer­ck re­veal 'prac­tice-chang­ing' da­ta for Trodelvy-Keytru­da com­bo in ag­gres­sive breast can­cer

From weeks to days: how Aizon In­tel­li­gent Agents trans­form phar­ma val­i­da­tion

Sanofi, Regeneron report underwhelming COPD data for IL-33 antibody, shares drop

FDA approves Moderna’s next-gen Covid vaccine, with limits on most healthy people

Summit’s disappointing survival readout raises stakes for full data

Updated: Patient dies in Rocket gene therapy trial, which is put on clinical hold by FDA

Summit says bispecific misses overall survival in closely-watched lung cancer study

Gilead, Merck reveal 'practice-changing' data for Trodelvy-Keytruda combo in aggressive breast cancer

From weeks to days: how Aizon Intelligent Agents transform pharma validation